BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 27682877)

  • 1. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
    El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
    Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resection.
    El-Mokadem I; Lim A; Kidd T; Garret K; Pratt N; Batty D; Fleming S; Nabi G
    BMC Cancer; 2016 Jul; 16():546. PubMed ID: 27465101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
    El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
    Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.
    Schraml P; Struckmann K; Bednar R; Fu W; Gasser T; Wilber K; Kononen J; Sauter G; Mihatsch MJ; Moch H
    Am J Pathol; 2001 Feb; 158(2):593-601. PubMed ID: 11159196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours.
    Natrajan R; Warren W; Messahel B; Reis-Filho JS; Brundler MA; Dome JS; Grundy PE; Vujanic G; Pritchard-Jones K; Jones C
    J Clin Pathol; 2008 Jan; 61(1):95-102. PubMed ID: 17369505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.
    Presti JC; Wilhelm M; Reuter V; Russo P; Motzer R; Waldman F
    J Urol; 2002 Mar; 167(3):1464-8. PubMed ID: 11832771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma.
    de Oliveira D; Dall'Oglio MF; Reis ST; Zerati M; Souza IC; Leite KR; Srougi M
    Urol Oncol; 2014 Jul; 32(5):601-6. PubMed ID: 24629495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma.
    Brunelli M; Eccher A; Gobbo S; Ficarra V; Novara G; Cossu-Rocca P; Bonetti F; Menestrina F; Cheng L; Eble JN; Martignoni G
    Mod Pathol; 2008 Jan; 21(1):1-6. PubMed ID: 17906617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder.
    Kimura F; Florl AR; Seifert HH; Louhelainen J; Maas S; Knowles MA; Schulz WA
    Br J Cancer; 2001 Dec; 85(12):1887-93. PubMed ID: 11747331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
    Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G
    J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin.
    Cook AL; Pollock PM; Welch J; Walsh MD; Bowman RV; Baumann KC; Hayward NK; Leonard JH
    Int J Cancer; 2001 Aug; 93(3):361-7. PubMed ID: 11433400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.
    La Rochelle J; Klatte T; Dastane A; Rao N; Seligson D; Said J; Shuch B; Zomorodian N; Kabbinavar F; Belldegrun A; Pantuck AJ
    Cancer; 2010 Oct; 116(20):4696-702. PubMed ID: 20629029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of genetic deletions on chromosome 3 in colorectal cancer: loss of 3p25-pter is associated with distant metastasis and poor survival.
    Tsai MH; Fang WH; Lin SH; Tzeng ST; Huang CS; Yen SJ; Chou SJ; Yang YC
    Ann Surg Oncol; 2011 Sep; 18(9):2662-70. PubMed ID: 21347784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
    Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.